Generation Bio Co.

NasdaqGS:GBIO 株式レポート

時価総額：US$88.2m

Generation Bio マネジメント

マネジメント 基準チェック /34

Generation Bioの CEO はGeoff McDonoughで、 Oct2017年に任命され、 の在任期間は 7.08年です。 の年間総報酬は$ 2.32Mで、 27.2%給与と72.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の2.75%を直接所有しており、その価値は$ 2.43M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と6.9年です。

主要情報

Geoff McDonough

最高経営責任者

US$2.3m

報酬総額

CEO給与比率27.2%
CEO在任期間7.1yrs
CEOの所有権2.8%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間6.9yrs

経営陣の近況

Recent updates

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

May 01
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Dec 07
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

Jul 11
Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Mar 11
We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

Nov 19
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Aug 05
We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Generation Bio GAAP EPS of -$0.66 misses by $0.04

Aug 04

Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Apr 20
Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Generation Bio: High-Risk, Medium-To-Low-Reward

Dec 30

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Nov 11
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Jul 28
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Mar 08
Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Jan 14
Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Generation Bio's insiders on buying spree, stock +4%

Jan 13

Generation Bio prices equity offering at $24.50

Jan 07

Generation Bio files to offer 7.5M shares

Jan 04

Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Dec 27
Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Generation Bio EPS misses by $0.01

Nov 10

CEO報酬分析

Generation Bio の収益と比較して、Geoff McDonough の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$145m

Jun 30 2024n/an/a

-US$158m

Mar 31 2024n/an/a

-US$169m

Dec 31 2023US$2mUS$630k

-US$127m

Sep 30 2023n/an/a

-US$124m

Jun 30 2023n/an/a

-US$127m

Mar 31 2023n/an/a

-US$134m

Dec 31 2022US$4mUS$606k

-US$137m

Sep 30 2022n/an/a

-US$135m

Jun 30 2022n/an/a

-US$136m

Mar 31 2022n/an/a

-US$129m

Dec 31 2021US$6mUS$583k

-US$119m

Sep 30 2021n/an/a

-US$112m

Jun 30 2021n/an/a

-US$101m

Mar 31 2021n/an/a

-US$88m

Dec 31 2020US$2mUS$516k

-US$81m

Sep 30 2020n/an/a

-US$72m

Jun 30 2020n/an/a

-US$68m

Mar 31 2020n/an/a

-US$65m

Dec 31 2019US$593kUS$424k

-US$61m

報酬と市場: Geoffの 総報酬 ($USD 2.32M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。

報酬と収益: Geoffの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Geoff McDonough (54 yo)

7.1yrs

在職期間

US$2,315,263

報酬

Dr. Cameron Geoffrey McDonough, also known as Geoff, M.D. serves as Independent Director of Third Harmonic Bio, Inc. since March 2024. He had been an Independent Director of Surface Oncology, Inc. since Fe...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Cameron McDonough
President7.1yrsUS$2.32m2.75%
$ 2.4m
Matthew Norkunas
Chief Financial Officer4.3yrsUS$1.14m0.086%
$ 75.7k
Matthew Stanton
Chief Scientific Officer5.5yrsUS$1.15m0.37%
$ 326.5k
Yalonda Howze
Chief Legal Officer & Secretary1.6yrsUS$1.21m0.021%
$ 18.7k
Mark Angelino
Co-Founder8.1yrsデータなしデータなし
Robert Kotin
Co-Founderno dataデータなしデータなし
Antoinette Paone
Chief Operating Officer2.8yrsデータなし0.024%
$ 21.2k
Jasmin Tower
Chief Human Resources Officer1.7yrsデータなしデータなし
Phillip Samayoa
Chief Strategy Officer2.2yrsデータなし0.18%
$ 161.2k

3.5yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: GBIOの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Cameron McDonough
President7.1yrsUS$2.32m2.75%
$ 2.4m
Jason Rhodes
Independent Chairman7.1yrsUS$181.21k0%
$ 0
Gustav Christensen
Independent Director6.9yrsUS$143.71k0.20%
$ 173.5k
Charles Rowland
Independent Director6.3yrsUS$151.21k0.80%
$ 705.9k
Anthony Quinn
Independent Director6.9yrsUS$143.71k0.24%
$ 213.0k
Andrew Scharenberg
Chairman of Scientific Advisory Boardno dataデータなしデータなし
Donald Nicholson
Independent Director6.9yrsUS$143.71k0.32%
$ 281.9k
Kevin Fitzgerald
Member of Scientific Advisory Boardno dataデータなしデータなし
Adrian Thrasher
Member of Scientific Advisory Boardno dataデータなしデータなし
Ronald H. Cooper
Independent Director3.7yrsUS$144.21k0.014%
$ 12.5k
Catherine Stehman-Breen
Independent Director6.9yrsUS$143.71k0.071%
$ 62.7k
Richard Thompson
Member of Scientific Advisory Board6.1yrsデータなしデータなし

6.9yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: GBIOの 取締役会 は 経験豊富 であると考えられます ( 6.9年の平均在任期間)。